Compare GSK plc (GSK) vs Direxion Daily TSLA Bull 2X Shares (TSLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Direxion Daily TSLA Bull 2X Shares — how do they compare? GSK plc trades at $50.26 (market cap $102.60B), while Direxion Daily TSLA Bull 2X Shares trades at $8.03. The key difference: GSK plc pays a 3.57% dividend while Direxion Daily TSLA Bull 2X Shares pays none, and GSK plc is trading nearer its 52-week high, Direxion Daily TSLA Bull 2X Shares nearer its low. Which is the better fit depends on your goals.
| GSK | TSLL | |
|---|---|---|
Market Cap | $102.60B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $61.18 | $23.03 |
52-Week Low | $38.22 | $6.74 |
Enterprise Value | $123.04B | — |
Dividend Yield | 3.57% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $50.27, down 3.62% today, with a bearish technical signal but strong fundamentals including a P/E of 16.02 and net income margin of 14.52%. Recent quarters show earnings beats, and the company announced a $2.52 billion cost-saving plan to boost its drug pipeline. Cash flow from operations remains robust at $7.74 billion for 2025.
The outlook is mixed: analyst consensus leans hold (55.18%) amid valuation concerns, but revenue growth and pipeline investments support long-term potential. Key risks include competitive pressures and regulatory uncertainty, as highlighted by recent news on vaccine policies. The stock offers a dividend yield with payments scheduled through 2026.
TSLL, the Direxion Daily TSLA Bull 2X Shares ETF, is trading at $7.975, down 2.86% on the day, with a bearish technical signal from moving averages and oscillators showing neutral momentum. The ETF aims to deliver twice Tesla's daily returns, amplifying volatility in a stock known for significant price swings. Recent news highlights its sensitivity to Tesla's performance, with Q2 earnings on July 22, 2026, potentially driving sharp moves.
The outlook for TSLL is highly speculative, tied directly to Tesla's stock volatility, offering leveraged upside but with elevated risk of losses even in rising markets. Investors face risks from daily rebalancing decay, market sentiment shifts, and Tesla-specific developments, requiring caution due to the ETF's non-traditional structure and lack of fundamental company metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Direxion Daily TSLA Bull 2X Shares
TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.
Read more on TSLL →
